HFS
Horizon Financial Services Portfolio holdings
AUM
$189M
1-Year Return
9.25%
This Quarter Return
+4.3%
1 Year Return
+9.25%
3 Year Return
+27.85%
5 Year Return
+25.82%
10 Year Return
–
AUM
$156M
AUM Growth
+$14M
(+9.9%)
Cap. Flow
+$8.46M
Cap. Flow
% of AUM
5.43%
Top 10 Holdings %
Top 10 Hldgs %
59.78%
Holding
266
New
206
Increased
24
Reduced
29
Closed
–
Top Buys
Top Sells
Sector Composition
| 1 | Consumer Discretionary | 1.47% |
| 2 | Technology | 1.08% |
| 3 | Healthcare | 0.93% |
| 4 | Utilities | 0.52% |
| 5 | Financials | 0.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
TE Connectivity
TEL
$61.7B
| $5.81K | ﹤0.01% |
+40
| New | +$5.81K |
|
152
SPDR S&P 500 ESG ETF
EFIV
$1.14B
| $5.72K | ﹤0.01% |
+113
| New | +$5.72K |
|
153
Wells Fargo
WFC
$253B
| $5.62K | ﹤0.01% |
+97
| New | +$5.62K |
|
154
Tesla
TSLA
$1.13T
| $4.04K | ﹤0.01% |
+23
| New | +$4.04K |
|
155
Carnival Corp
CCL
$42.8B
| $3.6K | ﹤0.01% |
+220
| New | +$3.6K |
|
156
Marvell Technology
MRVL
$54.6B
| $3.55K | ﹤0.01% |
+50
| New | +$3.55K |
|
157
SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
$14.4B
| $3.52K | ﹤0.01% |
66
-4,736
| -99% | -$253K |
|
158
Mercado Libre
MELI
$123B
| $3.02K | ﹤0.01% |
+2
| New | +$3.02K |
|
159
SPDR Portfolio S&P 600 Small Cap ETF
SPSM
$12.6B
| $2.97K | ﹤0.01% |
+69
| New | +$2.97K |
|
160
Thermo Fisher Scientific
TMO
$186B
| $2.91K | ﹤0.01% |
+5
| New | +$2.91K |
|
161
Moderna
MRNA
$9.78B
| $2.88K | ﹤0.01% |
+27
| New | +$2.88K |
|
162
Intuitive Surgical
ISRG
$167B
| $2.79K | ﹤0.01% |
+7
| New | +$2.79K |
|
163
Waters Corp
WAT
$18.2B
| $2.75K | ﹤0.01% |
+8
| New | +$2.75K |
|
164
Constellation Brands
STZ
$26.2B
| $2.73K | ﹤0.01% |
+10
| New | +$2.73K |
|
165
Bristol-Myers Squibb
BMY
$96B
| $2.71K | ﹤0.01% |
+50
| New | +$2.71K |
|
166
Boston Scientific
BSX
$159B
| $2.6K | ﹤0.01% |
+38
| New | +$2.6K |
|
167
Elevance Health
ELV
$70.6B
| $2.59K | ﹤0.01% |
+5
| New | +$2.59K |
|
168
IQVIA
IQV
$31.9B
| $2.53K | ﹤0.01% |
+10
| New | +$2.53K |
|
169
Vertex Pharmaceuticals
VRTX
$102B
| $2.51K | ﹤0.01% |
+6
| New | +$2.51K |
|
170
Incyte
INCY
$16.9B
| $2.39K | ﹤0.01% |
+42
| New | +$2.39K |
|
|
MRO
171
DELISTED
Marathon Oil Corporation
MRO
| $2.18K | ﹤0.01% |
+77
| New | +$2.18K |
|
172
APA Corp
APA
$8.14B
| $2.13K | ﹤0.01% |
+62
| New | +$2.13K |
|
173
Targa Resources
TRGP
$34.9B
| $2.13K | ﹤0.01% |
+19
| New | +$2.13K |
|
174
Enterprise Products Partners
EPD
$68.6B
| $2.07K | ﹤0.01% |
+71
| New | +$2.07K |
|
175
Oneok
OKE
$45.7B
| $2K | ﹤0.01% |
+25
| New | +$2K |
|